CI Investments Inc
BIO icon

CI Investments Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

CI Investments Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-221
Closed -$62K – 722
2025
Q3 		$62K Sell
221
-119
-35% -$32.4K ﹤0.01% 980
2025
Q2 		$82K Sell
340
-10
-3% -$2.36K ﹤0.01% 947
2025
Q1 		$85K Sell
350
-195
-36% -$58.7K ﹤0.01% 957
2024
Q4 		$179K Buy
545
+51
+10% +$17.3K ﹤0.01% 765
2024
Q3 		$165K Sell
494
-15
-3% -$4.76K ﹤0.01% 716
2024
Q2 		$139K Sell
509
-79
-13% -$23K ﹤0.01% 728
2024
Q1 		$203K Buy
588
+247
+72% +$81.2K ﹤0.01% 697
2023
Q4 		$110K Sell
341
-72
-17% -$22.6K ﹤0.01% 811
2023
Q3 		$148K Sell
413
-53
-11% -$20.4K ﹤0.01% 732
2023
Q2 		$177K Buy
466
+224
+93% +$91.2K ﹤0.01% 664
2023
Q1 		$116K Buy
242
+158
+188% +$74K ﹤0.01% 708
2022
Q4 		$35K Buy
84
+28
+50% +$11.3K ﹤0.01% 1008
2022
Q3 		$23K Buy
56
+22
+65% +$11K ﹤0.01% 1003
2022
Q2 		$17K Sell
34
-76
-69% -$39.6K ﹤0.01% 991
2022
Q1 		$62K Sell
110
-6
-5% -$3.62K ﹤0.01% 933
2021
Q4 		$88K Buy
116
+22
+23% +$16.5K ﹤0.01% 932
2021
Q3 		$70K Buy
+94
New +$70.4K ﹤0.01% 921
2020
Q3 		– Sell
-574
Closed -$259K – 934
2020
Q2 		$259K Buy
+574
New +$253K ﹤0.01% 510

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CI Investments Inc's BIO Position: Q4 2025 in Review

CI Investments Inc sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 221 shares — an estimated $62K sold.

CI Investments Inc first reported a position in BIO in Q2 2020 and held it in 18 quarters. The position peaked at $259K in Q2 2020. 399 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

  • CI Investments Inc reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 221 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $62K.
  • CI Investments Inc first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 18 quarters.
  • CI Investments Inc's Bio-Rad Laboratories Class A position peaked at $259K in Q2 2020.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.